13F
← All fund report cards

KEYBANK NATIONAL ASSOCIATION/OH

13F equity value
$27.4B
Positions
1,235
Top 10 concentration
34.2%
Quarters / total new picks
32 / 1,205
13F equity value over time
$0M$14B$28B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = 0.62, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.9%
t-stat
0.62
Quarterly win rate
50%
Annualized excess
-2.2%
$1 → follow vs universe
$1.77 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00820180630: follow 0.93020180930: follow 0.97920181231: follow 0.98220190331: follow 0.91920190630: follow 1.00120190930: follow 1.07620191231: follow 0.83720200331: follow 1.03920200630: follow 1.11420200930: follow 1.30320201231: follow 1.23620210331: follow 1.24720210630: follow 1.36720210930: follow 1.28720211231: follow 1.20720220331: follow 1.25520220630: follow 1.21220220930: follow 1.27020221231: follow 1.17820230331: follow 1.15720230630: follow 1.10120230930: follow 1.22120231231: follow 1.30520240331: follow 1.26220240630: follow 1.38020240930: follow 1.37620241231: follow 1.31520250331: follow 1.38620250630: follow 1.52920250930: follow 1.67320251231: follow 1.768 0.77 1.51 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1235 · 2026 Q1

Ticker Value Weight QoQ
IVV $2.1B
7.6%
HOLD
AAPL $1.2B
4.5%
HOLD
MSFT $1.0B
3.8%
HOLD
IEFA $922M
3.4%
ADD
NVDA $921M
3.4%
HOLD
GOOGL $872M
3.2%
HOLD
AMZN $652M
2.4%
HOLD
IJH $618M
2.3%
HOLD
JPM $526M
1.9%
HOLD
AVGO $518M
1.9%
TRIM
QUAL $484M
1.8%
TRIM
CCJ $483M
1.8%
TRIM
IJR $477M
1.7%
HOLD
VEA $401M
1.5%
HOLD
VOO $385M
1.4%
ADD
PH $350M
1.3%
TRIM
FNDX $347M
1.3%
ADD
RSP $344M
1.3%
TRIM
COST $333M
1.2%
HOLD
JNJ $330M
1.2%
HOLD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.